FDA scrutinizes lingering next-day effects of sleep drugs

08/14/2013 | New York Times (tiered subscription model), The

The FDA is taking greater interest in how safely insomnia drugs allow people to wake up amid concerns that their effects can last well into the next day. The effort comes as greater attention is being paid to drivers who are under the influence of prescription treatments. The FDA will ask drugmakers for more comprehensive driving tests of new sleep aids, and all drugs that can cause drowsiness will get a closer look.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief: